Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Low levels of HIV-1 RNA d… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation

Artikel i vetenskaplig tidskrift
Författare V. Dahl
J. Peterson
D. Fuchs
Magnus Gisslén
S. Palmer
R. W. Price
Publicerad i Aids
Volym 28
Nummer/häfte 15
Sidor 2251-2258
ISSN 0269-9370
Publiceringsår 2014
Publicerad vid Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 2251-2258
Språk en
Länkar dx.doi.org/10.1097/qad.000000000000...
Ämnesord central nervous system, cerebrospinal fluid, HIV, immune, inflammation, neurological, reservoir, CENTRAL-NERVOUS-SYSTEM, ACTIVE ANTIRETROVIRAL THERAPY, AIDS DEMENTIA, COMPLEX, TREATMENT INTENSIFICATION, NEUROCOGNITIVE DISORDERS, INFECTION, ERA, PLASMA, IMMUNOACTIVATION, IMPAIRMENT, Immunology, Infectious Diseases, Virology
Ämneskategorier Immunologi inom det medicinska området

Sammanfattning

Objective and design:Though combination antiretroviral therapy reduces the concentration of HIV-1 RNA in both plasma and cerebrospinal fluid (CSF) below the detection limit of clinical assays, low levels of HIV-1 RNA are frequently detectable in plasma using more sensitive assays. We examined the frequency and magnitude of persistent low-level HIV-1 RNA in CSF and its relation to the central nervous system (CNS) immune activation.Methods:CSF and plasma HIV-1 RNA were measured using the single-copy assay with a detection limit of 0.3 copies/ml in 70 CSF and 68 plasma samples from 45 treated HIV-1-infected patients with less than 40 copies/ml of HIV-1 RNA in both fluids by standard clinical assays. We also measured CSF neopterin to assess intrathecal immune activation. Theoretical drug exposure was estimated using the CNS penetration-efficacy score of treatment regimens.Results:CSF HIV-1 RNA was detected in 12 of the 70 CSF samples (17%) taken after up to 10 years of suppressive therapy, compared to 39 of the 68 plasma samples (57%) with a median concentration of less than 0.3 copies/ml in CSF compared to 0.3 copies/ml in plasma (P<0.0001). CSF samples with detectable HIV-1 RNA had higher CSF neopterin levels (mean 8.2 compared to 5.7nmol/l; P=0.0085). Patients with detectable HIV-1 RNA in CSF did not differ in pretreatment plasma HIV-1 RNA levels, nadir CD4(+) cell count or CNS penetration-efficacy score.Conclusion:Low-level CSF HIV-1 RNA and its association with elevated CSF neopterin highlight the potential for the CNS to serve as a viral reservoir and for persistent infection to cause subclinical CNS injury.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?